Siberian medical researchers named world’s best in clinical trials for diabetes

Print 03 February 2016
Marchmont Innovation News

The Tomsk-based Siberian State Medical University has been officially declared the world’s best center for clinical trials to test new drug candidates for type 2 diabetes, portal Science and Technologies RF  reported . The university received a gold certificate at the most recent Global Study Symposium of international researchers in Rome. 

The core of this activity is the team of endocrinologists led by Prof. Yulia Samoilova. Colleagues from foreign countries, such as the UK, India or Malaysia, also join to take part. 

“The Siberian Medical University today is a leading center for clinical trials in Russia, with a track record of more than 150 international clinical trial stages led by the university’s best professors and associate professors. We conduct experiments on the premises of our own clinics with modern equipment for diagnostics and therapy. All this enables us to fully meet international quality standards in our work,” Prof. Samoilova was quoted as saying. 

The university has been engaged in this activity since 2002 and is now authorized to conduct all the four stages of clinical trials and tests of various medical products. Top domestic and international pharmas are reported to partner with the Tomsk institution in this activity.

Source

Return